A trial comparing Metvix photodynamic therapy [methyl aminolevulinate] followed by Mohs micrographic surgery against Mohs micrographic surgery alone for the treatment of basal cell carcinoma

Trial Profile

A trial comparing Metvix photodynamic therapy [methyl aminolevulinate] followed by Mohs micrographic surgery against Mohs micrographic surgery alone for the treatment of basal cell carcinoma

Completed
Phase of Trial: Phase II

Latest Information Update: 28 Jan 2010

At a glance

  • Drugs Methyl aminolevulinate (Primary)
  • Indications Basal cell cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jan 2010 Status changed from not stated to completed as reported by ClinicalTrials.gov.
    • 28 Oct 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top